Wang YM - Search Results

1

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.

Jia JD, Hou JL, Yin YK, Tan DM, Xu D, Niu JQ, Zhou XQ, Wang YM, Zhu LM, Chen CW, He YW, Ren H, Wan MB, Wu SM, Wang QH, Wei L, Bao W, Dong Y, Trylesinski A. Jia JD, et al. Among authors: wang ym, wang qh. Hepatol Int. 2014 Jan;8(1):72-82. doi: 10.1007/s12072-013-9488-2. Epub 2013 Nov 28. Hepatol Int. 2014. PMID: 26202408

2

[Quasispecies and mutation of hepatitis B virus polymerase gene in lamivudine- treated patients].

Huang YP, Wang YM, Lan L, Fan Y. Huang YP, et al. Among authors: wang ym. Zhonghua Gan Zang Bing Za Zhi. 2003 Apr;11(4):235-8. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 12716526 Chinese.

3

[The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C].

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: wang ym. Zhonghua Gan Zang Bing Za Zhi. 2004 Feb;12(2):72-5. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 14980101 Clinical Trial. Chinese.

4

Impact of virus genotype on interferon treatment of patients with chronic hepatitis C: a multicenter controlled study.

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: wang ym. Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):369-74. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15313671 Clinical Trial.

5

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Xie Y, et al. Among authors: wang ym. Hepatobiliary Pancreat Dis Int. 2005 May;4(2):213-9. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15908318 Clinical Trial.

6

[Retreatment with interferon of relapsed chronic hepatitis C patients].

Li MH, Xie Y, Zhao H, Ou WN, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Li MH, et al. Among authors: wang ym. Zhonghua Gan Zang Bing Za Zhi. 2006 Jan;14(1):3-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16420755 Clinical Trial. Chinese.

7

[The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients].

Ma L, Zhao H, Xie Y, Li MH, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ. Ma L, et al. Among authors: wang ym. Zhonghua Gan Zang Bing Za Zhi. 2006 Aug;14(8):565-8. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16938164 Chinese.

8

[A double-blind, randomized, lamivudine-controlled clinical trial of DAIDING (adefovir dipivoxil) for lamivudine-resistant patients with chronic hepatitis B].

Wang YM, Chen YK, Zhang DZ, Lei BJ, Lu ZM, Yin YK, Yu YS. Wang YM, et al. Zhonghua Gan Zang Bing Za Zhi. 2006 Nov;14(11):803-5. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 17125603 Clinical Trial. Chinese.

9

[A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].

Yao GB, Zhu M, Wang YM, Xu DZ, Tan DM, Chen CW, Hou JL. Yao GB, et al. Among authors: wang ym. Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):891-5. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17313873 Clinical Trial. Chinese.

10

[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].

Jia JD, Hou JL, Yin YK, Xu DZ, Tan DM, Niu JQ, Zhou XQ, Wang YM, Zhu LM, He YW, Ren H, Wan MB, Chen CW, Wu SM, Chen YG, Xu JZ, Wang QH, Wei L, Ma H. Jia JD, et al. Among authors: wang ym, wang qh. Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):342-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17524265 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,591 results

Search Page